Quipt said its shares will be delisted from Nasdaq and the TSX at the close of business on March 17, 2026, following the completion of its previously announced arrangement. The delisting follows the acquisition of all outstanding Quipt shares by a purchaser backed by affiliates of Kingswood and Forager for USD 3.65 per share. Quipt also said it intends to apply to cease to be a reporting issuer in Canada and to terminate its public reporting obligations in Canada and the U.S. The company directed investors to sedarplus.ca and sec.gov for related filings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quipt Home Medical Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603160730PRIMZONEFULLFEED9672414) on March 16, 2026, and is solely responsible for the information contained therein.